Assertio Holdings | DEPO - Operating Profit

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $-3.05M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 6.62B 1.03B Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD 6.24B 318M Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Pfizer USD 4.65B 3.99B Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025